Proteolix Alternatives & Competitors
12 companies similar to Proteolix — Biopharmaceutical company engaged in the development and commercialization of in...
Companies similar to Proteolix
AlloMek Therapeutics LLC
Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.
SELLAS Life Sciences Group, Inc.
A late-stage clinical biopharmaceutical company focused on developing novel therapies for...
Entero Therapeutics (Nasdaq: ENTO)
A biopharma company focused on the development of targeted, non-systemic therapies for gas...
Rival Readout
Competing with Proteolix? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ambit
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology (Nasdaq: LIXT)
Adastra Pharmaceuticals
Adastra is committed to transforming cancer care.
BerGenBio ASA
Developing Innovative Drugs for Aggressive Diseases
Altheos
Pioneering novel treatments with promising small molecule drugs for glaucoma, supported by...
ImmuneOncia Therapeutics Inc.
Changing the Standard of cancer treatment by bringing Korea's 1st immuno-oncology drug
Coeptis Therapeutics
A biopharmaceutical company developing innovative cell therapy platforms for patients with...
MEDIBIOFARMA SL
To make disease-modifying treatments available to patients with serious or life-threatenin...
About Proteolix
Proteolix, a biopharmaceutical company founded in 2003, has established itself as a pioneer in the development and commercialization of innovative therapies targeting cancers and immunological conditions. Based in South San Francisco, United States, the company focuses on disrupting protein turnover in cells by inhibit...
Biopharmaceutical, Proteasome Inhibitors, Cancer Treatment, Carfilzomib, PR-171, Clinical Trials, Immunological Conditions, Protein Turnover Disruption, Oral Proteasome Inhibitors, Immunoproteasome Inhibitor, Therapeutic Development, South San Francisco, Intravenous Administration, Pharmaceutical Commercialization
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Proteolix: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Proteolix on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 17 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.